Prevalence of previously undiagnosed HIV*, proportion remaining undiagnosed after clinic visit and uptake of voluntary confidential testing among MSM attending 14 GUM clinics in England & Wales by region or country of birth, 1997–2002
| Undiagnosed prevalence* | Proportion remaining undiagnosed after clinic visit | Proportion accepting VCT | |||||
|---|---|---|---|---|---|---|---|
| (No of HIV positive samples*/no of samples tested*) | (No of HIV positive samples from individuals who could have been diagnosed at clinic visit but left clinic unaware of infection/no of HIV positive samples*) | (No of samples from individuals accepting VCT/no of samples tested*) | |||||
| % | 95% CI | n/N | % | n/N | % | n/N | |
| MSM, men who have sex with men. | |||||||
| *MSM with “previously undiagnosed HIV” includes samples from HIV infected MSM whose HIV infection was not diagnosed before clinic attendance, but may either have had a new diagnosis at the clinic visit or left remaining undiagnosed. It excludes men with a previously diagnosed HIV infection. | |||||||
| †Total includes men born in Australia and Oceania, Middle Eastern Crescent, North America, rest of Europe, and those where region of birth was not recorded. | |||||||
| Caribbean | 15.8 | (11.7 to 20.8) | 42/265 | 45.2 | 19/42 | 52.1 | 138/265 |
| Central/South America | 5.7 | (4.4 to 7.4) | 57/993 | 57.9 | 33/57 | 59.7 | 593/993 |
| Sub-Saharan Africa | 4.6 | (3.3 to 6.2) | 40/870 | 62.5 | 54.4 | 473/870 | |
| Asia | 3.7 | (2.4 to 5.3) | 27/739 | 51.9 | 14/27 | 56.4 | 417/739 |
| United Kingdom | 4.0 | (3.7 to 4.2) | 971/24 452 | 60.2 | 585/971 | 51.9 | 12 691/24 452 |
| Total† | 4.3 | (4.1 to 4.5) | 1595/37 039 | 60.2 | 960/1595 | 52.3 | 19 387/37 039 |